DOI: 10.21276/ajptr
Sun, 21 Apr 2019

Review: Gestational Diabetes Mellitus and Its Management


Rana Datta1, Subhangkar Nandy2*, Dipika Mondal1


1.Dept. of Pharmcology Gupta College of Technological Sciences, Asansol, (W.B.) India

2. Dept. of Pharmcology, Vedica College of Pharmacy, RKDF University, Bhopal, (M.P.) - India



Gestational diabetes mellitus (GDM) is defined as glucose intolerance of various degrees that is first detected during pregnancy.  Insulin deficiency in turn leads to chronic hyperglycemia with disturbances of carbohydrate, fat and protein metabolism. As with diabetes mellitus in pregnancy in general, babies born to mothers with gestational diabetes are typically at increased risk of problems such as being large for gestational age (which may lead to delivery complications), low blood sugar, and jaundice. There are 2 subtypes of gestational diabetes. One is Type A1 gestational diabetes where abnormal oral glucose tolerance test (OGTT) but normal blood glucose levels during fasting and 2 hours after meals; diet modification is sufficient to control glucose levels) and other is Type A2 gestational diabetes where abnormal OGTT compounded by abnormal glucose levels during fasting and/or after meals; additional therapy with insulin or other medications is required. The goal of treatment is to reduce the risks of GDM for mother and child. A repeat OGTT should be carried out 2–4 months after delivery, to confirm the diabetes has disappeared. Afterwards, regular screening for type 2 diabetes is advised. If a diabetic diet or G.I. Diet, exercise, and oral medication are inadequate to control glucose levels, insulin therapy may become necessary. Glyburide and Metformin, a second generation sulfonylurea, has been shown to be an effective alternative to insulin therapy. In one study, 4% of women needed supplemental insulin to reach blood sugar targets.

Key words: Gestational diabetes mellitus, etiology, Management, oral hypoglycemic agents.

[PDF]   Viewed: 1473   Downloaded: 130
  • Call for paper

    American Journal of PharmTech Research (AJPTR) is a peer-reviewed, bimonthly official international journal allowing access to abstracts and full-text.



  • Email & SMS Alerts

    Email/SMS alert system is one of the key features and gives update information about the submitted manuscript.


  • Article Statastics

    American Journal of PharmTech Research (AJPTR) provides unique facility for authors to know popularity of articles on basis of numbers of PDF download and views. It will display in tabulated format.

  • Online Submission

    American Journal of PharmTech Research (AJPTR) is one of the International open access journal devoted to various disciplines in science and technology.


web counter
web counter